Tardive dyskinesia, or TD, is a drug-induced movement disorder that can occur in individuals taking certain medications that block dopamine receptors in the brain. Most commonly, cases of TD are ...

TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that a new analysis from the European cohort of the RIM-TD open-label ...

Neurocrine Biosciences, maker of the first drug approved by the FDA to treat tardive dyskinesia, continues to throw its weight behind efforts to improve screening, monitoring and general awareness of ...

Tardive dyskinesia causes repeated, uncontrollable movements in the face and body. It is a side effect of some neuroleptic or antipsychotic medications. These medications may change dopamine activity ...

Nycole was compensated by Neurocrine Biosciences, Inc. to share her story. As a result of being on those medications, Nycole developed tardive dyskinesia (TD), a condition that affects approximately ...

Treatment for tardive dyskinesia (TD), a condition affecting the nervous system that causes uncontrollable body movements which can be triggered by antipsychotics or other medications that affect the ...

This is a preview. Log in through your library . Abstract Purpose Tardive dyskinesia (TD) is a common but serious hyperkinetic movement disorder and side effect of antipsychotic medications used to ...

Neurocrine Biosciences has shared survey data showing how tardive dyskinesia (TD) affects the ability of patients and caregivers to work, supporting the company’s case for timely treatment of the ...

TD Awareness Week is an opportunity to increase knowledge about tardive dyskinesia, an often misunderstood and stigmatized condition. Here are some ideas for advocacy. Tardive dyskinesia (TD) is an ...

Nycole S. 42 of Winfield, Kansas, started her mental health journey when she was diagnosed with bipolar disorder in her teens. “When I was in high school, I was placed in a mental institution, which ...